Krisztián Kása

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis

Tomáš Kalinčík, Timothy Spelman, María Trojano et al. · PLoS ONE · 2013 · 129 citations · Full text

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

Tim Spelman, Orla Gray, María Trojano et al. · Annals of Neurology · 2014 · 89 citations

Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome

Dániel Sandi, Tamás Biernacki, Dóra Szekeres et al. · Multiple Sclerosis and Related Disorders · 2017 · 41 citations

Isolated Syndrome, Neuropsychology, Hungarian Patients +10

Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype

Yuan Zhou, Suzi B. Claflin, Jim Stankovich et al. · Multiple Sclerosis Journal · 2019 · 17 citations · Full text